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RatsAbstract Objectives: Present study was aimed at developing an experimental model of oral muco-
sitis in rats using a combination of chemotherapeutic agent and radiation.
Study design: Female Wistar rats (150–200 g) were divided into 3 groups (n= 6). Rats in group
1 (normal control) and group 2 (mucositis control) were treated with vehicle. Rats in group 3 were
treated with L-glutamine (1 g/kg, p.o.; 15 days) before and after mucositis induction. Oral mucositis
was induced by busulfan (6 mg/kg, p.o.; 4 days) and the tongue exposed to infrared (IR) radiation
of intensity 40 mV/cm2 for 5 s on the 1st, 4th and 10th days of challenge using a tail ﬂick apparatus.
Parameters monitored were body weight, food intake, blood count and survival. Oral mucositis
score (OMS) was recorded daily. Histological changes of the irradiated tongue were assessed by
hematoxylin and eosin staining.
Results: Busulfan and IR radiation signiﬁcantly reduced body weight and food intake of the
mucositis control group as compared to normal control. Clear ulceration of the tongue reﬂected
in the OMS. Histopathology of the tongue revealed intense lymphocytic inﬁltration, decreased
thickness of squamous epithelial cell layer, decrease in number of blood vessels, and necrosis of cells
along with pseudo-membrane formation in the mucositis control group. These ﬁndings suggested
that oral mucositis was successfully induced and treatment with L-glutamine partially reversed these
conditions.
400 A. Patel et al.Conclusion: Oral mucositis was established successfully in rats by the combination of chemother-
apeutic agent and IR radiation. This may be a useful model for screening drugs in the treatment of
oral mucositis.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Mucositis is the inﬂammation of the mucous membrane coat-
ing the digestive tract. When it involves the mucous membrane
of the oral and oropharyngeal regions, it is termed as oral
mucositis (OM). OM is a major problem for cancer patients
receiving head and neck radiotherapy, stem cell transplanta-
tion and myelosuppressive chemotherapy for solid tumors
(Raber-Durlacher et al., 2010). It is characterized by the atro-
phy and ulceration of squamous epithelial cells, vascular tissue
damage and inﬁltration of inﬂammatory lymphocytes to the
basement region (Sonis, 1998). This injury occurs as a conse-
quence of chemotherapy (CT) and radiotherapy (RT), which
are targeted to eliminate rapidly dividing cancer cells. While
rapid cell division is essential for maintaining a healthy oral
mucosal epithelium, it is this normal function that renders
the oral epithelium an unintended target for CT and RT regi-
mens, in cancer patients with hematologic malignancies under-
going hematopoietic stem cell transplantation (Pico et al.,
1998).
Current treatments for oral mucositis in the clinical settings
are local anesthetics, paliferin, glutamine, caphsol mouth rinse,
amifostine and antimicrobial agents (Lionel et al., 2006;
Yamamura et al., 1998). However, there are no established
effective treatments for oral mucositis. Several animal models
were developed for the induction of oral mucositis e.g., mouse
lip (Parkins et al., 1983; Xu et al., 1984), mouse ventral tongue
mucosa (Moses and Kummermehr, 1986) and hamster cheek
pouch model (Sonis et al., 1990). Drawbacks of the aforemen-
tioned animal models were high mortality rate, un-intentional
exposure of organs such as brain and disturbed mucous
homeostasis (Bowen et al., 2011). In order to overcome the dis-
advantages, the present study was aimed at developing a sim-
ple and reliable model of oral mucositis in rats using
chemotherapy and IR radiation.Table 1 Oral mucositis scoring system.
Score Description
0 Normal
0.5 Slight pink
1.0 Slight red
2.0 Severe reddening
3.0 Focal desquamation
4.0 Exudation covering less than one half of the irradiated
mucosa
5.0 Virtually complete ulceration of mucosa2. Materials and methods
2.1. Animals
Eighteen female Wistar rats of 150–200 g, aged 14–16 weeks,
were issued from Central Animal Research Facility, Manipal
University, Manipal (License No. 94/1999 CPCSEA). The rats
were housed in polycarbonate cages and were provided free ac-
cess to standard rat food and ﬁltered water from standard per-
spex drinking bottles. All rats used in this study were allowed
to adapt to the housing conditions for one week prior to the
commencement of the study. All procedures in this study were
reviewed and approved by the Institutional Animal Ethics
Committee (IAEC), Manipal University, Manipal, India
(No. IAEC/KMC/70/2011–2012).2.2. Chemicals
Busulfan was purchased from Sigma–Aldrich Co. LLC, St.
Louis, MO, USA. The standard test drug, L-glutamine was
supplied by Nirlife Healthcare, Ahmedabad, Gujarat, India.
All chemicals and reagents used in the study were of labora-
tory grade and procured from Merck Specialities Private Lim-
ited, Mumbai, Maharashtra, India.
2.3. Experimental design
After the adaptation period, rats were divided into three
groups containing 6 in each group. Rats in group 1 and 2 re-
ceived vehicle and served as normal and mucositis control,
respectively. Rats in group 3 received the standard drug L-glu-
tamine (1 g/kg, p.o.). All the rats were pretreated with their
respective dosage regimens for 3 days.
2.3.1. Induction of oral mucositis
After pretreatment, oral mucositis in control and standard
group was induced by a combination of chemotherapy and
radiation.
2.3.1.1. Chemotherapy. Busulfan was used as a chemothera-
peutic agent and administered at the dose of 6 mg/kg by the
oral route for 4 days.
2.3.1.2. Radiation. As a source of radiation, tail ﬂick apparatus
(model 37360, Ugo Basile Srl, Comerio, VA, Italy) was used to
deliver IR radiation. The rats were anesthetized with light
ether and the dorsal surface of the tongue was exposed to IR
radiation of intensity 40 mV/cm2 for 5 s on the 1st, 4th and
10th days of busulfan challenge.
The drug treatment was continued during the busulfan/IR
radiation exposure and continued for 15 days. All the rats were
carefully observed during the experiment. The change in body
weight, feed intake, and oral mucositis score were recorded
daily. The dorsal surface of the tongue of each rat for oral
mucositis score was evaluated using a previously developed
Figure 1 Effect of busulfan/IR radiation on change in body weight, feed intake and oral mucositis score (OMS) at the end of study
period (15 days). Values are expressed as mean ± SEM. ap < 0.01 vs. normal control; bp < 0.01vs. mucositis control for body weight
changes and feed intake. ap < 0.01 vs. normal control using Kruskal–Wallis test followed by Dunn’s multiple comparison for OMS.
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vival rate was calculated.
Blood was withdrawn from retro orbital plexus under light
ether anesthesia and hematological parameters were measured
by veterinary blood cell counter (model PCE-210VET, ERMA
Inc., Tokyo, Japan) during the second week of experiment.
Survival rate was estimated.
2.3.2. Histopathology
All rats of standard group and normal control group were sacri-
ﬁced on the 15th day from the initiation of treatment by light
ether anesthesia followed by carotid bleeding. Tongue speci-
menswere collected,while thoseofmucositis groupwere collected
when they died on the 13th and 14th days from the initiation of
treatment. The specimens were stored in 10% neutralized buf-
fered formalin, and processed for histopathological ﬁndings.
2.4. Statistical analysis
All values were expressed as mean ± SEM for 6 animals in
each group. The data were analyzed by one way analysis of
variance (ANOVA) followed by Tukey’s multiple comparison
test using Prism 5.03 (GraphPad Software Inc., La Jolla, CA,
USA). Score for oral mucositis was analyzed by Kruskal–Wal-
lis test followed by Dunn’s multiple comparison tests. The level
of signiﬁcance was set at p< 0.05.
3. Results
3.1. Body weight
Following treatment with busulfan and exposure to IR a sig-
niﬁcant body weight reduction was observed in rats compared
to control. Treatment with standard drug, L-glutamine showed
a progressive increase in the body weight during the 15 days of
study period, and was signiﬁcant compared to mucositis con-
trol (Fig. 1).
3.2. Feed intake
The average food intake of normal control rats was found to
be 12.16 ± 0.40 g during the study period. Mucositis controlgroup showed a progressive decrease in food intake which
was signiﬁcant when compared to normal control from day 5
till the death of the animal. The decrease in feed intake may
be attributed to difﬁculty in chewing and swallowing because
of ulceration of the tongue. Treatment with L-glutamine
showed improvement in feed intake which was signiﬁcant
when compared to mucositis control (Fig. 1).
3.3. Oral mucositis score (OMS)
In normal rat group, no oral mucositis was observed and the
score was zero. In mucositis control the presence of clear ulcer-
ation in 4 out of 6 rats was observed and a maximum score of
5.0 was recorded. However, in 2 rats there was redness of the
mucosa though no ulcers were observed. The scoring was done
as shown in Table 1. Treatment with L-glutamine showed
reduction in OMS however it is not signiﬁcant compared to
mucositis control (Fig. 1).
3.4. Blood components
A signiﬁcant decrease in the leukocyte and platelet counts was
observed in mucositis control group compared to control,
while RBC remained unchanged. Treatment with L-glutamine
did not signiﬁcantly improve the parameters when compared
with mucositis control (Table 2).
3.5. Mortality rate
The mortality rate was determined during 15 days of study
period in each group. In mucositis control group, 3 rats died
on the 12th day and the remaining 3 rats died on the 13th
day of study period so the percentage of mortality was found
to be 100% at the end of study period. In L-glutamine
group, none of the rats died during 15 days of experiment
period, the percentage of mortality was found to be 0% at
the end of experiment. Treatment with L-glutamine showed
a protective effect against toxicity of busulfan by decreasing
mortality proportion and increasing survival proportion dur-
ing 15 days of experiment period compared to mucositis con-
trol (Fig. 2).
Table 2 Effect of busulfan/IR radiation on blood components.
Groups WBC
(·103 cells/m3)
LY
(·103 cells/m3)
MO
(·103 cells/m3)
GR
(·103 cells/m3)
RBC
(·106 cells/m3)
PLT
(·103 cells/m3)
Normal control 13.66 ± 0.46 11.43 ± 0.433 1.30 ± 0.05 1.11 ± 0.04 8.06 ± 0.07 612.50 ± 32.01
Mucositis control 3.80 ± 1.34a 3.28 ± 1.21a 0.21 ± 0.08a 0.35 ± 0.06a 6.37 ± 0.25 47.50 ± 13.95a
L-Glutamine (1 g/kg) 4.90 ± 1.39a 4.35 ± 1.27a 0.20 ± 0.07a 0.31 ± 0.04a 5.94 ± 0.42a 33.00 ± 5.00a
WBC––white blood cell; LY––lymphocyte; MO––monocyte; GR––granulocyte; RBC––red blood cell; PLT––platelets.
a Values are expressed as mean ± SEM. Level of signiﬁcance was set as p < 0.05 vs. normal control.
Figure 2 Percentage survival of different groups after busulfan/
infrared irradiation.
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Histological ﬁndings revealed that normal control showed in-
tact epithelium, no lymphocytic inﬁltration and normal num-
ber of blood vessels (Fig. 3A). In mucositis control, the
thickness of epithelial layer was altered along with lymphocyte
inﬁltration and reduction in the number of blood vessel which
indicates the presence of oral mucositis (Fig. 3B). Treatment
with L-glutamine (1 g/kg, p.o.) showed normal thickness of
the epithelial layer, normal number of blood vessels and ab-
sence of lymphocyte inﬁltration which indicates protection
against oral mucositis induced by busulfan and infrared radia-
tion (Fig. 3C).
4. Discussion
Mucositis is a common dose-limiting complication in patients
receiving systemic anticancer chemotherapy, bone marrowFigure 3 Histology of tongue sections of different groups after busulf
(C) glutamine (1 g/kg, p.o.).transplantation, and local irradiation for tumors in the head
and neck area (Raber-Durlacher et al., 2010). Oral mucosa
comprises membranes with high mitotic index (rapid epithelial
turnover and maturation rates). This renders the mucosa vul-
nerable to the adverse effects of chemotherapy and radiother-
apy (Sonis, 1998).
A complex mechanism is involved in the pathophysiology
of mucositis induced by chemotherapy and radiotherapy. Both
chemotherapy and irradiation generate reactive oxygen species
(ROS) which are deleterious to theDNAof epithelial cells. ROS
may induce a cascade of biological events such as activation of
transcription factors like nuclear factor-kappa B (NF-jB),
which in turn result in the synthesis of various pro-inﬂamma-
tory cytokines. These cytokines target epithelium, endothelium
and connective tissue, thereby causing tissue injury.
Chemotherapy and radiation also activate the apoptotic path-
way, leading to mucosal disintegration. This exposes the nerve
ends causing severe pain and bacterial infections (Sonis, 2004).
Some of the limiting factors associated with the currently
available animal models of oral mucositis are high mortality
rate, difﬁculty in attaining homogenous exposure and the need
for sophisticated instruments. In addition, owing to the highly
keratinized nature of the rat tongue, it is difﬁcult to induce
ulceration in rats (Bowen et al., 2011). The present animal
model involved the combination of busulfan and IR radiation.
Busulfan, a chemotherapeutic agent, known for its use in dif-
ferent types of cancer and in bone marrow transplantation,
is reported to induce mucositis (Zerbe et al., 1992).
IR radiation, a non-ionizing form of radiation, is employed
frequently in the treatment of sports injuries, muscle aches and
a few chronic diseases including the treatment of cancer (IC-
NIRP, 2006). In pre-clinical studies IR is used to induce pain
in tail ﬂick apparatus. Acute and chronic exposure to IR
may cause damage to the skin and eyes. Histopathological
analysis of the IR exposed skin showed vasodilatation and per-
ivascular accumulation of degranulated mast cells. Exposurean/infrared irradiation. (A) Normal control; (B) mucositis control;
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et al., 1983).
In the present context, rats treated with busulfan and ex-
posed to IR radiation showed clear mucositis and ulceration.
Histological study of the tongue revealed decreased thickness
of epithelium, lymphocyte inﬁltration and a decrease in the
number of blood vessels indicating induction of mucositis.
These ﬁndings are at par with the previous reports on animal
models of oral mucositis (Chen et al., 2007).
5. Conclusion
From the above ﬁndings, it can be concluded that an experi-
mental model of OM in rats was successfully established.
The method was simple, effective and easily reproducible. This
model can be used to assess the prophylactic and therapeutic
interventions used for oral mucositis.Acknowledgements
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